Evaluation of a Clinical Support Website for the Management of Common Mental Health Conditions in Primary Care on Compliance With Benzodiazepine Prescribing Recommendations (Psycho-MG)

MSPU de Pins-Justaret

Status: Begins enrollment in 3 months

Conditions: Benzodiazepine Use

Treatments: Other: Training

Study type: Interventional

Funder types: Other

Identifiers

NCT07379073

Psycho-MG

Details and patient eligibility

About

This cluster-randomized study aims to evaluate the impact of a web-based clinical support tool on adherence to recommended maximum durations for benzodiazepine prescriptions among new users in primary care. General practitioners (GPs) participating in the study will have access to the website, which provides evidence-based algorithms for the management of common mental health conditions, including anxiety and sleep disorders. Prescription data and patient characteristics will be extracted from the French national health insurance database (DCIR). The primary outcome is the proportion of new benzodiazepine users whose prescriptions comply with recommended duration guidelines. Multilevel logistic regression models will assess the intervention effect, adjusting for patient- and GP-level factors.

Enrollment: 100 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Being a general practitioner or a specialist in general medicine.
• Practicing in the Occitanie region.
• Working in private practice.
• Being registered under Sector 1 fee agreements.
• Providing informed consent to participate in the study.
• Having computer equipment in the medical office, available during consultation (desktop, laptop, tablet, or smartphone) with internet access.

Exclusion criteria

- Physicians who have been practicing for less than two years, as they are unlikely to have sufficient retrospective data on prescription reimbursements for their patients.

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

100 participants in 2 patient groups

Experimental Group (trained on PsychoMG website)

Experimental group

Description:

Training intervention on benzodiazepine prescribing with access to the PsychoMG website providing evidence-based clinical decision algorithms for anxiety and sleep disorder management.

Treatment:

Other: Training

Control Group

No Intervention group

Description:

Training intervention on benzodiazepine prescribing without access to the PsychoMG website providing evidence-based clinical decision algorithms for anxiety and sleep disorder management.